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Synopsis 
Abstract 
Background 
Surgical site infections are wound infections that occur after invasive (surgical) procedures. 
Preoperative bathing or showering with an antiseptic skin wash product is a well-accepted 
procedure for reducing skin bacteria (microflora). It is less clear whether reducing skin 
microflora leads to a lower incidence of surgical site infection.  
Objectives 
To review the evidence for preoperative bathing or showering with antiseptics for the prevention 
of hospital-acquired (nosocomial) surgical site infection.  
Search strategy 
We searched the Cochrane Wounds Group Specialised Register (21 July 2004), the Cochrane 
Central Register of Controlled Trials (The Cochrane Library Issue 3, 2004), MEDLINE (January 
1966 to September 2004), EMBASE (January 1985 to September 2004) and reference lists of 
articles.  
Selection criteria 
Randomised controlled trials comparing any antiseptic preparation used for preoperative full-
body bathing or showering with non-antiseptic preparations in patients undergoing surgery.  
Data collection & analysis 
Two authors independently assessed trial quality and extracted data. Study authors were 
contacted for additional information.  
Main results 
Six trials involving a total of 10,007 participants were included. Three of the included trials had 
three comparison groups. The antiseptic used in all trials was 4% chlorhexidine gluconate 
(Hibiscrub). Three trials involving 7691 participants compared this antiseptic with a placebo. 
Bathing with chlorhexidine compared to a placebo did not result in a statistically significant 
reduction in the surgical site wound infection rate; the relative risk (RR) was 0.91 (95% 
confidence interval (CI) 0.80 to 1.04). Three trials of 1443 participants compared bar soap with 
chlorhexidine. When results of the three trials were combined no differences were detected, the 
RR was 1.02 (95% CI 0.57 to 1.84). Two trials of 1042 patients compared bathing with 
chlorhexidine with no washing. No difference was found in the postoperative surgical site wound 
infection rate between patients who washed with chlorhexidine compared with patients who did 
not wash preoperatively, the RR was 0.36 (95% CI 0.17 to 0.79).  
 
Reviewers' conclusions 
Washing preoperatively with chlorhexidine offers no benefit over placebo or bar soap in 
preventing surgical site wound infection.  
Background 
Surgical site infections (SSIs) are wound infections that occur after invasive procedures. Surgical 
site infection (SSI) is the third most frequently hospital-acquired (nosocomial) infection (Smyth 
2000) amongst hospital patients. The Centers for Disease Control and Prevention (CDC) have 
used the National Nosocomial Infections Surveillance (NNIS) system to monitor nosocomial 
infections in acute care hospitals in the United States since 1970. Between 1986 and 1996 they 
studied approximately 600,000 operations. Surgical site infections developed after three per cent 
(15,523) of these operations. During the period of data collection, 551 patients (out of the 15,523 
who developed an SSI) died, and 77% of deaths were attributed to the infection (Mangram 
1999). Apart from the morbidity and mortality associated with SSIs, there are significant cost 
implications. A recent study, using the NNIS system found that it cost over $3000 more to treat a 
patient with an SSI than a non-infected patient. These costs were attributable to a greater 
likelihood of admission to an intensive care unit (ICU), a longer than usual post-operative stay 
(five days) and an increased rate of hospital re-admission (Kirkland 1999). Potential litigation is 
also a concern (Rubinstein 1999). Consequently, prevention of surgical site infection has become 
a priority for health care facilities.  
Identification of SSIs depends upon the interpretation of clinical and laboratory findings. The 
CDC has developed a set of standardised criteria for defining SSIs in an attempt to make 
surveillance and rate calculation more accurate and amenable to comparison. SSIs are classified 
as being: superficial incisional (involving only skin or subcutaneous tissues); deep incisional 
(involving deeper soft tissue and fascia); or organ/space (involving any other part of the anatomy 
that was opened or manipulated). To help predict the likelihood or SSI risk, surgical wounds can 
be assessed preoperatively as ‘clean’ or ‘non-clean’ and classified into one of four categories 
with clearly defined definitions: Class 1 (clean), Class II (clean-contaminated), Class III 
(contaminated) and Class IV (dirty/infected) (Mangram 1999). Clean wounds are defined as 
uninfected surgical wounds in which the respiratory, alimentary, genital or uninfected urinary 
tract are not present and in which no inflammation is encountered. Non-clean wounds are 
defined according to the anatomical area of operation, aetiology of wound, presence of existing 
clinical infection, and intra-operative contamination. Since clean wounds are less likely to 
become infected SSIs following clean surgery are probably due to either (1) patient risk factors: 
such as age, nutritional status, diabetes and obesity; (2) risk factors associated with the 
procedure: including preoperative hand and forearm antisepsis, length of surgical procedure and 
surgical technique; or (3) risk factors associated with preoperative preparation of the patient: for 
example, antimicrobial prophylaxis, preoperative hair removal and preoperative antiseptic 
showering (Mangram 1999).  
Skin is not sterile. Indeed, thousands of bacteria live on skin permanently and contribute to 
health by maintaining a steady colony that inhibits establishment of harmful yeast and fungal 
infections. These bacterial populations are referred to as the ‘resident flora’. A number of 
bacteria are present on the skin for a short period due to transfer from other people or the 
environment, and these constitute the ‘transient flora’. At present, whole body bathing or 
showering with skin antiseptic in order to prevent SSIs is a widespread practice before surgery, . 
The aim of washing is to make the skin as clean as possible by removing transient flora and some 
resident flora. Chlorhexidine 4% in detergent ('Hibiscrub' or 'Hibiclens') or a triclosan 
preparation is usually used for this purpose, and there is evidence that the numbers of bacteria on 
the skin are reduced when it is applied (Byrne 1992; Kaiser 1988). Moreover, use of a skin 
antiseptic on consecutive days not only reduces microbial counts from baseline measurements, 
but also reduces the counts progressively over time (Paulson 1993). Although this body of 
evidence demonstrates the effectiveness of antiseptics as skin cleansing agents, the more 
important question is whether preoperative bathing or showering with an antiseptic reduces the 
incidence of surgical site infection. In a 10-year prospective surveillance study, the surgical site 
infection rate was lower amongst patients showering with hexachlorophene before surgery than 
in those who either did not shower or showered using a non-medicated soap (Cruse 1980). In 
addition, at least two studies have used a before and after design to test the effect of introducing 
preoperative showering with triclosan to control methicillin-resistant Staphylococcus aureus 
(MRSA) SSIs. In the first of these, showering before and after surgery was introduced to reduce 
the MRSA SSI rate. However, this intervention was only one of a battery of measures 
introduced, so it was not possible to determine the independent effect of preoperative showering 
(Brady 1990). In the second, the incidence of MRSA SSI was reduced amongst orthopaedic 
patients after presurgical showering with triclosan was introduced, however, the patients were 
also treated with nasal mupirocin for five days before surgery (Wilcox 2003). While these 
observational studies provide some support for the practice of preoperative showering with an 
antiseptic, the evidence is not definitive.  
Patterns of resistance have developed with some antiseptics (Thomas 2000), leading to calls to 
restrict their use to situations where effectiveness can be demonstrated. In addition, 
hypersensitivity to chlorhexidine is not uncommon. Consequently, the potential benefit of 
bathing/showering with antiseptics needs to be assessed alongside the potential for harm 
(Beaudounin 2004; Krautheim 2004). As it is unclear whether the use of antiseptics for 
preoperative bathing or showering leads to lower rates of SSIs, a systematic review is justified to 
guide practice in this area.  
Objectives 
To review the evidence for preoperative bathing or showering with antiseptics for the prevention 
of nosocomial surgical site infection.  
 
Criteria for considering studies for this review 
Types of studies 
All published and unpublished randomised controlled trials that allocate surgical patients 
individually or by cluster, comparing any antiseptic preparation used for preoperative full body 
or partial body bathing or showering, with non-antiseptic preparations. Quasi-randomised trials 
were not included (e.g. trials that allocate treatment by day of the week, medical record number, 
sequential admitting order).  
Types of participants 
Men, women and children undergoing any type of surgery in any setting.  
Types of interventions 
Any type of antiseptic solution (any strength, any regimen at any time before surgery) used for 
preoperative tub or bed bathing or showering compared with:  
(1) non-antiseptic soap;  
(2) non-antiseptic soap solution;  
(3) no shower or bath.  
Antiseptic solutions were defined as liquid soap products containing an antimicrobial ingredient 
such as chlorhexidine, triclosan, hexachlorophene, povidone-iodine or benzalkonium chloride. 
Trials comparing different types of antiseptic with each other would also be compared if 
evidence for the benefit of showering was either equivocal, or if there was evidence of benefit 
with showering with antiseptic.  
Types of outcome measures 
Trials were considered if they reported the primary outcome:  
Primary outcome  
Surgical site infection. (NB despite development of standardised criteria for defining SSI, the 
diagnosis of SSIs continues to vary between studies. We therefore accepted the definition used 
by the original authors to determine the proportion of patients who developed any SSI before or 
after discharge).  
 
Secondary outcomes  
(1) Mortality (any cause).  
(2) Allergic reactions (e.g. contact dermatitis, anaphylaxis).  
(3) Postoperative antibiotic use.  
(4) Length of hospital stay.  
(5) Re-admission to hospital.  
(6) Cost.  
(7) Other serious infection or infectious complication, such as septicaemia or septic shock.  
(8) Postoperative fever higher than 38 degrees on at least two occasions more than four hours 
apart, excluding the day of surgery. 
Secondary outcomes were only extracted if the primary outcome was reported.  
Search strategy for identification of studies 
See: Wounds Group Strategy.  
We searched the Cochrane Wounds Group Specialised Register (July 2004).  
The Cochrane Wounds Group Specialised Register is maintained by searching:  
(1) MEDLINE, CINAHL and EMBASE;  
(2) the Cochrane Central Register of Controlled Trials (CENTRAL);  
(3) handsearching of wound care journals and relevant conference proceedings.  
 
There was no restriction by language or date of publication. Reference lists of all retrieved 
articles were searched for additional studies. Manufacturers of antiseptic products were contacted 
in order to obtain any unpublished data.  
In addition, we searched MEDLINE (2002 to present) to allow for any lag-time in the Wounds 
Group Specialised Register using the following strategy:  
This looks like a search for CENTRAL  - did you adapt this for MEDLINE? – can you clarify 
What about EMBASE – you say this has been searched in the abstract to the review 
The search date for the Wounds Register is July 2004 – I have asked Ali to run an additional 
search as there has been quite a time delay and its good for the searching to be as up to date as 
possible. 
1. DETERGENTS explode all trees (MeSH)  
2. POVIDONE-IODINE explode all trees (MeSH)  
3. CHLORHEXIDINE explode all trees (MeSH)  
4. DISINFECTION explode all trees (MeSH)  
5. ALCOHOL DETERGENTS explode all trees (MeSH)  
6. detergent*  
7. Betadine  
8. chlorhexidine  
9. (povidone and iodine)  
10. (alcohol or alcohols or soap)  
11. ANTI-INFECTIVE AGENTS LOCAL single term (MeSH)  
12. antiseptic*  
13. iodophor*  
14. (#1 or #2 or #3 or #4 or #5 or #6 or #7)  
15. (#8 or #9 or #10 or #11 or #12 or #13)  
16. (#14 or #15)  
17. SURGICAL WOUND INFECTION explode all trees (MeSH)  
18. PREOPERATIVE CARE explode all trees (MeSH)  
19. PERIOPERATIVE CARE explode all trees (MeSH)  
20. (preoperative near care)  
21. (perioperative near care)  
22. (wound* near infect*)  
23. (surg* near infect*)  
24. (surg* near wound*)  
25. (#17 or #18 or #19 or #20 or #21 or #22 or #23 or #24)  
26. shower*  
27. bath*  
28. wash*  
29. clean*  
30. (#26 or #27 or #28 or #29)  
31. (#16 and #25 and #30)  
 
Methods of the review 
Selection of studies 
Both authors independently assessed the titles and abstracts of references identified by the search 
strategy. Full reports of all potentially relevant trials were then retrieved for assessment of 
eligibility based on the inclusion criteria. Reference lists of retrieved studies were screened to 
identify further studies, which were also retrieved. Differences of opinion were settled by 
consensus or referral to the editorial base of the Wounds Group.  
 
Methodological quality assessment 
The two authors assessed the quality of eligible trials independently. A pre-defined quality 
assessment form, based on the assessment criteria listed below, was used. Once again, 
disagreements between authors were resolved by consensus or referral to the editorial base of the 
Wounds Group. When possible, contact was made with investigators of included trials to resolve 
any ambiguities.  
Trials that met the eligibility criteria were coded as follows for:  
 
Generation of random allocation sequence  
A = Adequate (if the method used was described and the resulting sequences were 
unpredictable);  
B = Unclear (if the method was not described);  
C = Inadequate (for sequences such as alternative allocation).  
 
Allocation concealment  
A = Adequate (if participants and the investigators enrolling participants could not foresee 
assignment);  
B = Unclear (method not described);  
C = Inadequate (if investigators enrolling participants could foresee next assignment).  
 
Blinding of intervention  
A = Double blind (neither the participant nor the person providing the intervention knew which 
treatment was given);  
B = Single blind (the participant or person providing the intervention knew which treatment was 
given);  
C = No blinding (all parties were aware of treatment);  
D = Unclear (method not described).  
 
Blinding of outcome assessment  
A = Outcome assessment was blinded (person performing assessment did not know which 
treatment had been given);  
B = Cannot tell whether outcome assessment was blinded;  
C = Outcome assessment was not blinded (person performing assessment was aware of treatment 
given).  
 
Intention to treat analysis (analysed according to allocated treatment group, irrespective of 
adherence to treatment)  
A = Yes, intention to treat analysis performed;  
B = Cannot tell;  
C = No, intention to treat analysis not performed.  
 
Completeness of primary outcome reporting  
A = Adequate (more than 90% of all participants randomised were included in the analysis);  
B = Unclear (not clear how many participants were originally randomised);  
C = Inadequate (less than 90% of those randomised were included in the analysis).  
 
High quality trials were defined as those receiving an A rating for the criterion of allocation 
concealment (central computerised randomisation service or sealed opaque envelopes) and for 
blinding of the intervention (from the person providing the intervention and from trial 
participants).  
 
Data extraction 
The following data were extracted from each study by both authors independently using a piloted 
data extraction sheet: type of study, study setting, number of participants, sex, mean age, 
predisposing risk factors, type of antiseptic solutions, use of prophylactic antibiotics, procedure 
and timing for full body wash, period of community follow-up, all primary and secondary 
outcome descriptions and outcome measures reported, including infection rates and authors' 
conclusions.  
 
Data synthesis 
Analyses was performed using the RevMan 4.2 software. Relative risks and 95% confidence 
intervals (CI) were calculated for dichotomous outcomes, and mean differences and 95% CI 
calculated for continuous outcomes. Results of comparable trials were pooled using the fixed-
effect model and 95% CI. Heterogeneity was investigated by calculating the I2 statistic (Higgins 
2002). If evidence of significant heterogeneity was identified (a value greater than 50%), 
potential sources of heterogeneity were explored and a random-effects approach to the analysis 
undertaken. A narrative review of eligible studies was conducted where statistical synthesis of 
data from more than one study was not possible or considered inappropriate.  
 
One trial (Rotter) used a multi-centre design but patients were allocated individually to the 
treatment or control arm. Two trials (Hayek & Whilborg) allocated clusters of patients to each 
intervention. Results were not analysed using the number of clusters as the unit of analysis but 
analysed as if the allocation was by individual. This was necessary because the authors of the 
trial did not use the cluster as the unit of analysis. Analysing cluster trials in this way has the 
potential to over-estimate the effect of treatment (Mollison 2000).  
 
We included all eligible trials in the initial analysis and carried out sensitivity analyses to 
evaluate the effect of trial quality. This was done by excluding those trials most susceptible to 
bias based on the following quality assessment criteria: those with inadequate allocation 
concealment; high levels of post randomisation losses or exclusions; or unblinded outcome 
assessment; or where blinding of outcome assessment was uncertain.  
 
Sub-group analyses were to be:  
(1) Clean surgery compared with clean contaminated surgery; however data were not reported in 
a format that allowed this to be assessed.  
(2) One preoperative bath or shower compared with more than one preoperative bath or shower.  
(3) Cluster-randomised trials compared with individually randomised controlled trials; this was a 
post hoc analysis because cluster randomised trials were found, which had been analysed as 
though randomisation had been by individual. 
 
Description of studies 
For a detailed description of studies see table of 'Characteristics of included studies'.  
 
Our search strategy identified 43 articles. Full-text assessment was conducted of 16 potentially 
eligible papers. Ten of these papers were excluded from further review because the studies were 
not randomised, or were randomised trials evaluating other interventions (e.g. preoperative scrub 
solutions), or other outcomes (e.g. intraoperative wound colonisation). The six remaining trials 
reported outcomes for 10,007 participants and were included in the review (Byrne 1992; 
Earnshaw 1989; Hayek 1987; Randall 1983; Rotter 1988; Wihlborg 1987). The results of these 
six trials were reported in nine publications. Four authors of included trials (Byrne 1992; 
Earnshaw 1989; Randall 1983; Wihlborg 1987) and one non-included trial author (Garabaldi 
1988) responded to queries about study methods and/or requests for additional unpublished 
information.  
 
Participants  
The age range of the participants in the six included studies was nine to 90 years old. The trials 
enrolled men, women and children booked for elective surgery.  
 
Byrne 1992 included clean and potentially infected cases but all other studies were of clean 
surgery. Two studies included general surgical patients (Byrne 1992; Hayek 1987); one involved 
participants undergoing general, orthopaedic and vascular surgery (Rotter 1988); and one 
included biliary tract, inguinal hernia or breast surgery (Wihlborg 1987). The remaining studies 
involved only one type of surgery (Earnshaw 1989 (vascular reconstruction); Randall 1983 
(vasectomy)). Participants in the vasectomy study (Randall 1983) were day patients.  
 
Four of the centres in which the studies were conducted were in the United Kingdom (Byrne 
1992; Earnshaw 1989; Hayek 1987; Randall 1983); one was in Sweden (Wihlborg 1987) and one 
(Rotter 1988) included a number of European centres (eight from Denmark, five from the United 
Kingdom, four from Sweden, two from Austria, and one from both Germany and Italy).  
 
All of the studies included the presence of pus in their definition of infection. Earnshaw and 
Hayek also included patients with severe cellulites and Randal included the discharge of serous 
fluid 
 
Interventions  
There were inconsistencies in both the interventions and the control procedures between studies. 
One trial compared a regimen that included three preoperative washes (Byrne 1992), three trials 
included a two-wash regimen (Earnshaw 1989; Hayek 1987; Rotter 1988), and participants in 
two trials had only one wash preoperatively (Randall 1983; Wihlborg 1987).  
 
The breakdown of the studies according to timing of bathing were as follows:  
• One wash on admission, a second on the night before surgery and a third on the morning of 
surgery (Byrne 1992).  
• One wash immediately after admission, and a second on the day of surgery (Hayek 1987).  
• One wash on the day before surgery, and a second on the day of surgery (Rotter 1988).  
• Two washes preoperatively, timing not specified (Earnshaw 1989).  
• One wash on the day before surgery only (Wihlborg 1987).  
• One wash not more than one hour before surgery (Randall 1983).  
 
Three of the studies had two arms (Byrne 1992; Earnshaw 1989; Rotter 1988), whilst three had 
three arms (Hayek 1987; Randall 1983; Wihlborg 1987). The breakdown of studies according to 
bathing products is as follows:  
 
• 4% Chlorhexidine gluconate (Hibiscrub) detergent solution compared with a matching 
placebo (i.e. the same detergent without chlorhexidine) (Byrne 1992; Hayek 1987; Rotter 
1988).  
• Hibiscrub compared with bar soap (Earnshaw 1989; Hayek 1987; Randall 1983).  
• Chlorhexidine with no shower or bath (Randall 1983; Wihlborg 1987).  
• Chlorhexidine: full body bathing compared with localised washing, i.e. restricted to the part 
of the body to be subjected to surgery  (chlorhexidine used in both arms of trial) (Wihlborg 
1987).  
 
Antibiotic prophylaxis was used routinely in only one study (Earnshaw). In three other studies 
(Byrne, Rotter, Whilborg) there was no attempt to alter the treating surgeons’ usual routine but in 
these studies, the reported rate of prophylactic antibiotic use was low (1% - 15%). Hayek & 
Randall did not mention whether antibiotics were used before surgery. 
 
 
Outcome measures  
Primary outcome  
The primary outcome measure for this review, the effectiveness of preoperative washing or 
showering with an antiseptic in preventing surgical site infection, was reported in all of the 
studies (Byrne 1992; Earnshaw 1989; Hayek 1987; Randall 1983; Rotter 1988; Wihlborg 1987).  
 
Secondary outcomes  
The secondary outcomes of the review were reported as follow:  
(1) Mortality (any cause) was reported in two studies (Byrne 1992; Earnshaw 1989).  
(2) Allergic reactions (e.g. contact dermatitis, anaphylaxis) were reported in one study (Byrne 
1992).  
(3) Post operative antibiotic use was not reported in any of the studies.  
(4) Length of hospital stay was not reported in any of the studies.  
(5) Re-admission to hospital was not reported in any of the studies.  
(6) Cost was reported in one study (Byrne 1992).  
(7) Other serious infection or infectious complication, such as septicaemia or septic shock was 
not reported in any of the studies.  
(8) Postoperative fever exceeding 38 degrees on at least two occasions more than four hours 
apart, excluding the day of surgery, was not reported in any of the studies.  
 
Methodological quality of included studies 
Two of the six included studies (Byrne 1994; Rotter 1988) were assessed as being of high 
methodological quality using the assessment criteria described above.  
 
Generation of random allocation sequence  
All studies mentioned a process of randomisation. The method of generating the random 
allocation sequence was adequate in some studies (Byrne 1992; Randall 1983; Rotter 1988; 
Wihlborg 1987) and unclear in others (Earnshaw 1989; Hayek 1987). In three of the studies, the 
random sequence was computer generated (Byrne 1992; Randall 1983; Rotter 1988). One study 
used block randomisation in groups of six using computer generated random numbers (Byrne 
1994). A large multi-centre study used cluster randomisation whereby randomisation was carried 
out for each surgical unit in the study by means of computer generated numbers (Rotter 1988). 
Personal correspondence with authors of two of the studies confirmed that they used either 
computer generated random numbers (Randall 1983) or a randomisation list (Wihlborg 1987).  
 
Allocation concealment  
As with generation of the allocation sequence, concealment of allocation was adequate in some 
studies (Byrne 1992; Randall 1983; Rotter 1988; Wihlborg 1987) and unclear in others 
(Earnshaw 1989; Hayek 1987).  
 
Blinding of intervention  
Blinding of intervention in two studies was by a double blind method (Byrne 1994; Rotter 1988). 
In one study there was single blinding of the intervention in two arms of the study but no 
blinding in the third arm of the study (Hayek 1988). In the remaining studies, no there was no 
blinding of intervention (Earnshaw 1989; Randall 1983; Wihlborg 1987).  
 
Blinding of outcome assessment  
In four of the studies, there was blinding of outcome assessment (Byrne 1992; Earnshaw 1989; 
Hayek 1987; Rotter 1988). In one of the studies there was no blinding of the outcome assessment 
(Wihlborg 1987). In one study it is unclear whether blinding of outcome assessment occurred 
(Randall 1983).  
 
Sample size calculations 
None of the trials reported how the sample size was calculated. 
 
Intention to treat analysis  
In one study analysis by intention to treat was not done (Byrne 1992). For all of the other studies 
it could not be determined whether analysis by intention to treat occurred (Earnshaw 1989; 
Hayek 1987; Randall 1983; Rotter 1988; Wihlborg 1987).  
 
Completeness of reporting  
All of the studies reported the status of all people entered into the trials. One study reported only 
one of 94 patients lost to follow up (Randall 1983). Byrne 1992 reported a 99.35% completeness 
of follow up. All other studies reported that all patients were followed up (Earnshaw 1989; 
Hayek 1987; Wihlborg 1987). In one study, 140 patients out of the 2953 enrolled were 
withdrawn from the study for several reasons: failure to have two preoperative showers, not 
meeting inclusion criteria, transferring out of unit, or no identification number on patient 
protocol (Rotter 1988). Despite this, the study reports on all remaining patients (n = 2813), 
resulting in 95.2% completeness of reporting.  
 
Hayek and Byrne recorded SSIs during hospitalisation and then followed patients for 6 weeks 
after hospital discharge, Rotter followed patients for 3 weeks, Randall for 7 days, Whilborg 
monitored SSI’s that occurred in hospital and among those returning for an outpatient visit and 
Earnshaw reviewed patients twice weekly until hospital discharge. 
Results 
This review includes outcomes data from six trials with a total of 10,007 participants. Six 
comparisons were undertaken: chlorhexidine 4% versus placebo (Figure: Comparison 01), 
(Byrne, Hayek rotter) chlorhexidine 4% versus bar soap (Figure: Comparison 02),(earnshaw 
hayeek and Randall) chlorhexidine versus no bath or shower (Figure: Comparison 03) (randall & 
whilborg) whole body wash with chlorhexidine versus washing only that part of the body to be 
submitted to surgery (Figure: Comparison 04) Whilborg) more than one wash versus one wash 
(hayek, rotter, Randall, earnshaw and byrne (Figure: Comparison 05), and one post hoc 
comparison, individual allocation versus cluster allocation (randall rotter earnshaw byrne, 
Hayek, whilborg). A random-effect meta-analysis was used when significant heterogeneity was 
present (i.e. where the I2 value was greater than 50%) .  
 
Chlorhexidine versus placebo (Figure: Comparison 01)  
This comparison includes three trials (Byrne 1992; Hayek 1987; Rotter 1988) of 7691 
participants and includes four outcomes (surgical site wound infection, allergic reactions, 
mortality and cost).  
 
Surgical site wound infection (Figure: Comparison 01, outcome 01)  
Participants in each trial had more than one wash. Hayek (1987) and Rotter (1988) included 
patients having elective surgery whereas Byrne (1992) included patients undergoing clean or 
potentially infected surgery. None of the individual trials found that washing with chlorhexidine 
had a statistically significant effect on surgical site infection. All of the trials were included in 
the meta-analysis. When compared with placebo, bathing with chlorhexidine did not result in a 
statistically significant reduction in the surgical site wound infection rate (chlorhexidine 9.2%, 
placebo 10.1%); the relative risk (RR) was 0.91 (95% confidence interval (CI) 0.80 to 1.04).  
 
Surgical site wound infection - high quality trials (Figure: Comparison 01, outcome 02)  
For this outcome we conducted a separate analysis of trials rated as high quality by the criteria 
described in the ‘Methods of the Review’ section (Byrne 1992; Rotter 1988) and obtained a 
similar result, the RR was 0.95 (95% CI 0.82 to 1.10). The event rate was 9.3% for the 
chlorhexidine group and for 9.7% for the placebo group.   
 
Allergic reaction (Figure: comparison 01, outcome 03)  
One study (Byrne 1992) included allergic reaction as an outcome. There were 19 events reported, 
nine (0.5%) in the chlorhexidine group and 10 (0.6%) in the placebo group; no evidence of a 
statistically significant difference in allergy rate, the RR was 0.89 (95% CI 0.36 to 2.19).  
 
Mortality (any cause)  
One trial in this comparison reported mortality data (Byrne 1992). A total of 23 patients died in 
the study period but these were not reported in groups.  
 
Cost  
There was an estimate of cost in one study (Byrne 1992). The average total cost (based on drug 
costs, hotel costs, dressing costs and outpatients’ costs) of patients washing with chlorhexidine 
was UK £936 compared with UK £897 when patients washed with a placebo. Standard deviation 
were not reported but, according to the authors, this difference was not statistically significant.  
 
Chlorhexidine versus bar soap (Figure: Comparison 02)  
Three trials compared washing with chlorhexidine with washing with bar soap (Earnshaw 1989; 
Hayek 1987; Randall 1983).  These included 1443 participants and reported on two outcomes 
(surgical site wound infection and mortality). Due to small numbers in two of the trials 
(Earnshaw 1989; Randall 1983) and methodological inconsistencies in the Hayek 1987 trial (all 
patients did not receive the same washing instruction and the bar soap was found to contain 
antimicrobial properties and was changed during the study) estimates of effect are imprecise and 
need to be interpreted with caution. Significant heterogeneity was present in this comparison, so 
we used a random–effects model for the meta-analysis. There are two possible explanations for 
heterogeneity. First, different types of surgery were conducted in each trial; Earnshaw included 
patients undergoing vascular reconstruction, Hayek included patients booked for routine elective 
surgery and Randall included only vasectomy patients. Alternatively, a different definition of SSI 
was used by Randall, who included patients with a wound which discharged pus or serous fluid, 
whereas Earnshaw and Hayek defined SSI as the discharge of pus.  
 
Surgical site wound infection (Figure: Comparison 02, outcome 01)  
Two of the trials that compared washing with chlorhexidine with washing with soap (Earnshaw 
1989; Randall 1983) found no difference between the treatments in postoperative surgical site 
wound infection rate. However, one trial (Hayek 1987), reported statistically fewer surgical site 
wound infections when patients washed preoperatively with chlorhexidine compared with 
patients who washed with soap; the RR was 0.70 (95% CI 0.51 to 0.96). When results of the 
three trials were combined no differences were detected, the RR was 1.02 (95% CI 0.57 to 1.84), 
an event rate of 10.9% for chlorhexidine and 13.6% for bar soap.  
 
Mortality (any cause)  
Two patients died in the Earnshaw 1989 trial but these were not reported by group.  
 
Chlorhexidine versus no wash (Figure: Comparison 03)  
Two trials compared washing with chlorhexidine with not washing (Randall 1983; Wihlborg 
1987).  These included 1042 patients and reported on surgical site wound infection only. There 
was significant statistical heterogeneity between the two trials (P value < 0.01), which was 
possibly due to different sample sizes, and clinical heterogeneity, outpatient surgery versus 
inpatient surgery, and different types of included patients. Randall (1983) enrolled patients 
undergoing vasectomy, whereas Wihlborg (1987) included patients undergoing elective surgery 
of the biliary tract, inguinal hernia or breast cancer. In addition, Randall defined SSI as a wound 
which discharged pus or serous fluid, whereas Whilborg defined SSI as the discharge of pus, so a 
random-effects model was used for the meta-analysis.  
 
Surgical site wound infection (Figure: Comparison 03, outcome 01)  
Randall (1983) found no difference in the postoperative surgical site wound infection rate 
between patients who washed with chlorhexidine compared with patients who did not wash 
preoperatively. In the other trial, Wihlborg (1987) found that chlorhexidine wash when compared 
with no wash resulted in a reduction in the number of patients with a surgical site infection; the 
RR was 0.36 (95% CI 0.17 to 0.79). When the results from both trials were combined, they 
showed no overall benefit of washing with chlorhexidine over not washing, the event rate for 
chlorhexidine was 3.7% and when patients did not follow a protocol for washing it was 6.2%.  
 
Chlorhexidine total body wash versus localised wash (Figure: Comparison 04)  
One trial compared washing the whole body with chlorhexidine with a localised wash (Wihlborg 
1987).  This trial included 1093 participants and assessed one outcome; surgical site wound 
infection.  
 
Surgical site wound infection (Figure: Comparison 04, outcome 01)  
Data from one trial making this comparison (Wihlborg 1987) showed a reduction in surgical site 
wound infections when whole body washing (1.7%) was compared with localised washing 
(4.1%); the RR was 0.40 (95% CI 0.19 to 0.85).  
 
More than one wash versus one wash (Comparison 05) 
The treatment effect for the primary outcome was compared based on number of washes before 
surgery. A total of 7,683 participants in four of the trials had more than one wash (Hayek Rotter, 
Earnshaw, and Byrne). In one trial (randall), 62 patients had one wash.  
 
Surgical site wound infection (Figure: Comparison 05, outcome 01) 
For surgical site infection, the effect of chlorhexidine was similar regardless of whether the 
participant had more than one wash, the RR was 0.91 (95% CI 0.80 to 1.04) 
 (Hayek, Rotter, Earnshaw, and Byrne)) or one wash, the RR was 1.13 (95% CI 0.57 to 2.21 
(Randall)). The infection rate in both the chlorhexidine group and the control group was much 
higher in the one wash group compared to the group who had more than one wash. This may 
have been because the definition used for infection was different in the one wash (randall) study 
compared with other studies in the comparison, possibly inflating the event rate. 
  
Individual versus cluster randomisation (Comparison 06) 
Treatment effect in this comparison included four trials of 6,430 participants where allocation 
was by individual (Randall, rotter earnshaw and byrne) and two trials of 2,367 participants where 
allocation was by cluster Hayek & Whilborg). In both of the cluster trials, treatment was 
randomly allocated by the ward to which patients were admitted. 
 
Surgical site wound infection (Figure: Comparison 06, outcome 01) 
Among the trials that allocated patients individually (Randall, rotter earnshaw and byrne), there 
was no difference in the surgical site wound infection rate between participants  washing with 
chlorhexidine compared with participants washing with other products, the RR was 0.97 (95% 
CI 0.84 to 1.12). In trials that allocated participants by cluster, both authors reported fewer 
surgical site infections in wards where chlorhexidine was used pre-operatively, in one of these 
trials (Whilborg) the difference was statistically significant, the RR was 0.36 (95% CI 0.17 to 
0.79) When results of both of these trials were combined, there was a strong trend favouring 
Chlorhexidine, the RR was 0.90 (95% CI 0.79 – 1.02). This difference is probably due to the 
effect of the cluster design and the way data has been analysed; as if randomisation had been by 
individual rather than by cluster, which tends to over estimate the treatment effect. Methods for 
correctly analysing data when reported in this way are described in the Cochrane Handbook 
(version 4.2.5 pp154 -157) but information about the number in each cluster and number of 
events in each cluster or the intracluster correlation must be known. This information was not 
extractable from either study.  
 
Discussion 
Widespread use of preoperative antiseptic washing agents to prevent surgical site wound 
infection continues. This review summarises trial data from over 10,000 patients, that compared 
washing with chlorhexidine with either a placebo solution, or a bar soap, or no preoperative 
washing at all. There was no evidence that washing with chlorhexidine reduced the incidence of 
surgical site wound infection. The results of the review are strengthened by the heterogeneous 
nature of the participants; the trials included men, women and children undergoing a range of 
surgeries that were either clean or potentially infected, and undertaken in both inpatient and 
outpatient settings. These studies were published over a nine-year period between 1983 and 
1992. Despite the fact that there have been no recent studies published in this area, it is unlikely 
that further trials would achieve different results. The product used in the trials (chlorhexidine 
0.4%) remains unchanged and the quality of the two largest trials (that included over 6000 
participants) was high, concealing the randomisation process and blinding the interventions. 
Both of these trials also included community follow up.  
One of the limitations of the review was the quality of some of the studies. Community follow-
up was attempted in only three studies, none of the authors provided justification for their sample 
sizes and in both studies where a cluster design was used, analysis was conducted as if 
participants had been allocated individually. However, results from the high quality trials and 
from trials where participants were allocated individually, no statistical benefit for the use of 
chlorhexidine for preoperative washing could be demonstrated. We conducted two post hoc 
analysis of the number needed to treat (NNT) to avoid one infection. In one we included only the 
high quality trials where the NNT was 136, in the second we included trials where patients were 
allocated individually, the NNT for this group was 434. 
Only one of the trials provided data for other outcomes in which we were interested. Byrne 
(1992) assessed complications or undesirable effects attributable to the use of an antiseptic. In 
this trial patients assigned to chlorhexidine use were no more likely to suffer an adverse reaction 
than those assigned to the placebo group. There were no comparisons with bar soap for this 
outcome. Byrne (1992) also assessed the cost of washing with chlorhexidine compared with 
placebo and found a non-significant cost reduction in the placebo group. Costs included length of 
hospital stay, so, even though the SSI rate was 1.1% higher in the placebo group, using a placebo 
still resulted in an overall cost benefit.  
Reviewers' conclusions 
Implications for practice 
This review has been unable to demonstrate that preoperative washing with chlorhexidine offers 
a statistically significant benefit over placebo or bar soap in preventing surgical site wound 
infection in patients undergoing elective surgery. A trend towards lower costs was demonstrated 
when a placebo was used.  
Implications for research 
Issues of effectiveness have been adequately addressed. It is unlikely that further trials would 
result in any clear benefit for chlorhexidine over other non-antiseptic wash products. 
Comparisons between placebo and other antiseptics could be addressed in future trials.  
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Characteristics of included studies 
Study Methods Participants Interventions Outcomes Notes Alloca
concea
t 
Byrne 
1992 
RCT. 
Generation 
of random 
number 
sequence: 
adequate.  
Blinding of 
intervention: 
double. 
Blinding of 
outcome: 
yes. 
Completenes
s of 
reporting: 
yes. 
Power 
calculation: 
yes. 
Follow-up 
period: 6 
weeks after 
discharge. 
3733 patients 
undergoing 
elective or 
potentially 
contaminated 
surgery. 
Exclusions: 
patients 
undergoing day 
surgery, 
emergency 
surgery, re-
operation or 
contaminated 
surgery, and 
those unable to 
comply with the 
washing 
procedure, or 
with a known 
allergy to 
chlorhexidine, or 
having more 
than the standard 
prophylactic 
antibiotic 
regimen. 
Baseline 
comparability: 
age, sex, type of 
surgery, 
ASEPSIS score. 
All patients 
showered 3 times 
(on admission, 
the night before 
surgery and the 
morning of 
surgery) using 50 
ml of either:  
(1) 4% 
chlorhexidine or 
(2) a placebo. 
Written 
instructions were 
provided to all 
participants. 
Primary 
outcome: 
Wound 
infection, 
defined as 
discharge of pus 
from a wound 
(for inpatients or 
outpatients); or 
an ASEPSIS 
score greater 
than 10. 
(1) 256/1754 
(14.6%) 
(2) 272/1735 
(15.7%). 
Secondary 
outcomes: 
Death, allergic 
reactions, cost. 
Data were 
extracted from 3 
papers reporting 
results from the 
one study (Lynch 
1992 & Byrne 
1994). There were 
minor 
discrepancies in 
numbers reported 
between the 3 
studies. The 
version reported is 
the definitive study 
(personal 
correspondence 
with author). 
A 
Earnsha
w 1989 
RCT. 
Generation 
of random 
allocation 
sequence: 
unclear. 
Blinding of 
intervention: 
none. 
Blinding of 
outcome: 
66 patients 
undergoing 
vascular 
reconstruction 
surgery. 
Exclusions: none 
reported. 
Baseline 
comparability: 
stated that 
groups were 
All patients had 
2 baths:  
(1) painted entire 
body with 
undiluted 4% 
chlorhexidine 
followed by 
rinsing in the 
bath. Precise 
instructions 
given. 
Primary 
outcome: 
Wound 
infection, 
defined as 
discharge of pus 
from a wound; 
one patient with 
severe cellulitis 
was also 
included. 
Different washing 
information 
provided to 
participants in each 
group. 
B 
yes. 
Completenes
s of 
reporting: 
yes. 
Power 
calculation: 
no. 
Follow-up 
period: until 
hospital 
discharge. 
similar, no data. (2) Non-
medicated soap 
used. No specific 
instructions 
provided. 
(1) 8/31 26% 
(2) 4/35 11.4%. 
Secondary 
outcome:  
Death. 
Hayek 
1987 
Cluster RCT.  
Generation 
of random 
allocation 
sequence: 
unclear. 
Blinding of 
intervention: 
none. 
Blinding of 
outcome: 
yes. 
Completenes
s of 
reporting: 
yes. 
Power 
calculation: 
no. 
Follow-up 
period: until 
hospital 
discharge. 
2015 patients 
undergoing 
routine surgery. 
Exclusions: 
those receiving 
antibiotics or 
with an existing 
infection. 
Baseline 
comparability: 
age, sex, 
preoperative skin 
preparation, 
wound 
classification, 
proportion who 
washed their 
hair.  
All patients had 
either a shower 
or bath on the 
day before and 
morning of their 
operation. 
(1) 
Chlorhexidine 
4%. Instruction 
card for washing 
provided. 
(2) Placebo. 
Instruction card 
for washing 
provided. 
(3) Bar soap. No 
washing 
instructions 
provided. (Five 
months into the 
study, the bar 
soap was found 
to have 
antimicrobial 
properties and 
was changed.) 
Primary 
outcome: 
Wound 
infection, 
defined as 
discharge of pus 
from a wound or 
erythema or 
swelling 
considered 
greater than 
expected. 
(1) 62/689 
(9.0%) 
(2) 83/700 
(11.7%) 
(3) 80/626 
(12.8%). 
Data were 
extracted from 2 
papers reporting 
results from one 
study (see Hayek 
1988) 
B 
Randall 
1983 
RCT. 
Generation 
of random 
allocation 
sequence: 
adequate. 
Blinding of 
intervention: 
94 patients 
undergoing 
vasectomy.  
Exclusions: none 
stated. 
Baseline 
comparability: 
none stated. 
1) One 
preoperative 
shower with 
Chlorhexidine 
4%. 
2) One shower 
with normal 
soap. 
Primary 
outcome: 
Wound 
infection, 
defined as 
discharging 
either purulent 
or serous fluid. 
 A 
none. 
Blinding of 
outcome: 
cannot tell. 
Completenes
s of 
reporting: 
yes. 
Power 
calculation: 
no. 
Follow-up 
period: 1 
week after 
discharge. 
3) No shower. 1) 12/32 
(37.5%) 
2) 10/30 
(33.3%) 
3) 9/32 (28.1%). 
Rotter 
1988 
Cluster RCT. 
Generation 
of random 
number 
sequence: 
adequate.  
Blinding of 
intervention: 
double. 
Blinding of 
outcome: 
yes. 
Completenes
s of 
reporting: 
yes. 
Power 
calculation: 
no. 
Follow-up 
period: 3 
weeks after 
discharge. 
2953 patients 
undergoing 
elective clean 
surgery. 
Exclusions: 
patients with 
fever > or = to 
37.5 on the day 
of or day before 
surgery, 
infection remote 
from operation 
site, antibiotics 
given within 7 
days prior to 
surgery for 
infection, 
incarcerated 
inguinal hernia, 
radical 
mastectomy.  
Baseline 
comparability: 
age, sex, type of 
surgery, 
antibiotic 
prophylaxis, hair 
washed, hair 
removal method, 
wound drainage. 
All patients had 
two showers, one 
on the day before 
and one on the 
day of surgery 
using 50 ml of 
either 
1) Chlorhexidine 
4% or 
2) Placebo 
solution for each 
shower. Special 
application 
instructions were 
provided to all 
participants. 
 
Primary 
outcome: 
Wound 
infection, 
defined as 
inflammation of 
the surgical 
wound with 
discharge of pus, 
spontaneous 
and/or after 
surgical 
intervention that 
occurs during 
hospitalisation 
or during routine 
follow-up. 
1) 37/1413 
(2.6%) 
2) 33/1400 
(2.4%). 
 A 
Wihlborg RCT. 1530 patients 1) Washed entire Primary This study was A 
1987 Generation 
of random 
number 
sequence: 
adequate.  
Blinding of 
intervention: 
none. 
Blinding of 
outcome: no. 
Completenes
s of 
reporting: 
yes. 
Power 
calculation: 
no. 
Follow-up 
period: until 
hospital 
discharge.  
undergoing 
elective surgery 
of the biliary 
tract, inguinal 
hernia and breast 
cancer.  
Exclusions: none 
stated. 
Baseline 
comparability: 
age, duration of 
surgery > 2 
hours, steroids, 
diabetes, 
malignancy 
(other than 
breast cancer), 
type of surgery. 
body with 
chlorhexidine on 
the day before 
surgery using 
two consecutive 
applications 
followed by 
rinsing under the 
shower. 
2) Washed only 
that part of the 
body to be 
submitted to 
surgery. 
3) No 
chlorhexidine 
wash. 
outcome: 
Wound 
infection, 
defined as a 
definite 
collection of pus 
emptying itself 
spontaneously or 
after incision.  
1) 9/541 (1.7%) 
2) 23/552 
(4.2%) 
3) 20/437 (4.6). 
conducted over a 7 
year period, 1978-
1984. 
It was unclear from 
the text whether 
patients allocated 
to the 'no 
chlorhexidine 
wash' group had 
any preoperative 
shower. Three 
patients died and 
were not included 
in the analysis. 
Strength of wash 
solution not stated.
 
Abbreviations: 
RCT = randomised controlled trial 
ASEPSIS =  
ml = millilitre 
> = greater than (in these instances) 
Characteristics of excluded studies 
 
Study Reason for exclusion 
Ayliffe 1983 Not a randomised controlled trial. 
Bergman 1979 No data on wound infection. 
Not a randomised controlled trial. 
Brandberg 1980 Not a randomised controlled trial. 
Local wash versus full body wash with chlorhexidine. 
Byrne 1994 Duplicate results (Byrne 1992).*** 
Garabaldi 1988 No non-antiseptic group. 
Did not report infection rates by group. 
Hayek 1988 Duplicate results (Hayek 1987).*** 
Leigh 1983 Not a randomised controlled trial. 
Lynch 1992 Duplicate results (Byrne 1992).*** 
Newsom 1988 Not a randomised controlled trial. Patients were allocated by month. 
Wells 1983 Not a randomised controlled trial. 
Did not report infection rates by group. 
*** these should not be excluded studies they are duplicate citations of an included study and 
therefore should be added to the Included studies reference list as secondary citations 
References to studies 
References to included studies 
• List the first six authors and then use “et al”. Comma before “et al” is optional but should 
be consistent.  
• Use full journal title. (You can check the full journal name in OVID)  
• Page number should be in  this format, (example): 324-8; 556-60; 1093-8 (Not 324-328; 
1093-1098) 
 
Byrne 1992 {published data only} 
* Byrne DJ, Napier A, Cuschieri A. The value of whole body disinfection in the prevention of 
post-operative wound infection in clean and potentially contaminated surgery. A prospective, 
randomised, double blind, placebo controlled trial. Surg Res Comm 1992;12:43-52. 
Earnshaw 1989 {published data only} 
* Earnshaw JJ, Berridge DC, Slack RC, Makin GS, Hopkinson BR. Do preoperative 
chlorhexidine baths reduce the risk of infection after vascular reconstruction? European Journal 
of Vascular Surgery 1989;3323-6.(4):323-6. 
Hayek 1987 {published data only} 
* Hayek LJ, Emerson JM, Gardner AM. A placebo-controlled trial of the effect of two 
preoperative baths or showers with chlorhexidine detergent on postoperative wound infection 
rates. Journal of Hospital Infection 1987;10(2):165-72. 
Randall 1983 {published and unpublished data} 
* Randall PE, Ganguli L, Marcuson RW. Wound infection following vasectomy. British Journal 
of Urology 1983;55(5):564-7. 
Rotter 1988 {published data only} 
* Rotter ML, Larsen SO, Cooke EM, Dankert J, Daschner F, Greco D, et al. A comparison of the 
effects of preoperative whole-body bathing with detergent alone and with detergent containing 
chlorhexidine gluconate on the frequency of wound infections after clean surgery. The European 
Working Party on Control of Hospital Infections. Journal of Hospital Infection 1988;11(4):310-
20. 
Wihlborg 1987 {published data only} 
* Wihlborg O. The effect of washing with chlorhexidine soap on wound infection rate in general 
surgery. A controlled clinical study. Annales Chirurgiae et Gynaecologiae 1987;76(5):263-5. 
References to excluded studies 
Ayliffe 1983 {published data only} 
Ayliffe GA, Noy MF, Babb JR, Davies JG, Jackson J. A comparison of pre-operative bathing 
with chlorhexidine-detergent and non-medicated soap in the prevention of wound infection. 
Journal of Hospital Infection 1983;4(3):237-44. 
Bergman 1979 {published data only} 
Bergman BR, Seeberg S. A bacteriological evaluation of a programme for preoperative total 
body-washing with chlorhexidine gluconate performed by patients undergoing orthopaedic 
surgery. Archives of Orthopedic Trauma Surgery 1979;95(1):59-62. 
Brandberg 1980 {published data only} 
Brandberg A, Holm J, Hammarsten J, Schersten T. Post-operative wound infections in vascular 
surgery - effect of pre-operative whole body disinfection by shower-bath with chlorhexidine 
soap. Royal Society of Medicine International Congress an Symposium Series;23:71-5. 
Byrne 1994 {published data only} 
Byrne DJ, Lynch W, Napier A, Davey P, Malek M, Cuschieri A. Wound infection rates: the 
importance of definition and post-discharge wound surveillance. Journal of Hospital Infection 
1994;26(1):37-43. 
Garabaldi 1988 {published data only} 
Garibaldi RA, Skolnick D, Lerer T, Poirot A, Graham J, Krisuinas E, et al. The impact of 
preoperative skin disinfection on preventing intraoperative wound contamination. Infection 
Control and Hospital Epidemiology 1988;9(3):109-13. 
Hayek 1988 {published data only} 
Hayek LJ, Emerson JM. Preoperative whole body disinfection--a controlled clinical study. 
Journal of Hospital Infection 1988;11(Supplement B):15-9. 
Leigh 1983 {published data only} 
Leigh DA, Stronge JL, Marriner J, Sedgwick J. Total body bathing with 'Hibiscrub' 
(chlorhexidine) in surgical patients: a controlled trial. Journal of Hospital Infection 
1983;4(3):229-35. 
Lynch 1992 {published data only} 
Lynch W, Davey PG, Malek M, Byrne DJ, Napier A. Cost-effectiveness analysis of the use of 
chlorhexidine detergent in preoperative whole-body disinfection in wound infection prophylaxis. 
Journal of Hospital Infection 1992;21(3):179-91. 
Newsom 1988 {published data only} 
Newsom SW, Rowland C. Studies on perioperative skin flora. Journal of Hospital Infection 
1988;11(Supplement B):21-6. 
Wells 1983 {published data only} 
Wells FC, Newsom SW, Rowlands C. Wound infection in cardiothoracic surgery. The Lancet 
1983;1(8335):1209-10. 
* indicates the primary reference for the study 
Other references 
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Beaudounin 2004 
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hypersensitivity to chlorhexidine: literature review. Allergie et Immunologie (Paris) 
2004;36:123-6. 
Brady 1990 
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Higgins 2002 
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Kaiser 1988 
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Comparisons and data 
01 Chlorhexidine 4% versus placebo 
01.01 Surgical site wound infection 
 
Study ID Chlorhexidine n Chlorhexidine N Placebo n Placebo N 
Byrne 1992 256 1754 272 1735 
Hayek 1987 62 689 83 700 
Rotter 1988 37 1413 33 1400 
 
01.02 Surgical site wound infection (high quality studies) 
 
Study ID Chlorhexidine 4% n Chlorhexidine 4% N Placebo n Placebo N
Byrne 1992 256 1754 272 1735 
Rotter 1988 37 1413 33 1400 
 
01.03 Allergic reaction 
 
Study ID Chlorhexidine 4% n Chlorhexidine 4% N Placebo n Placebo N
Byrne 1992 9 1754 10 1735 
 
02 Chlorhexidine 4% versus bar soap 
02.01 Surgical site wound infection 
 
Study ID Chlorhexidine 4% n Chlorhexidine 4% N Bar soap n Bar soap N
Earnshaw 1989 8 31 4 35 
Hayek 1987 62 689 80 626 
Randall 1983 12 32 10 30 
 
03 Chlorhexidine 4% versus no shower or bath 
03.01 Surgical site wound infection 
 
Study ID Chlorhexidine 4% n Chlorhexidine 4% N No shower or bath n No shower or bat
Randall 1983 12 32 9 32 
Wihlborg 1987 9 541 20 437 
 
04 Chlorhexidine full wash Vs partial wash 
04.01 Surgical site wound infection 
 
Study ID CHX full wash n CHX full wash N CHX partial wash n CHX partial wash 
Wihlborg 1987 9 541 23 552 
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